| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-05 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.19 | 6e-05 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |